Citadel Advisors
BIOC

Citadel Advisors’s Biocept, Inc. BIOC Stock Holding History

Citadel Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-274
Closed -$2.79K – 15696
2023
Q1 		$2.79K Sell
274
-73
-21% -$1.06K ﹤0.01% 14108
2022
Q4 		$5.51K Buy
+347
New +$7.66K ﹤0.01% 13988
2022
Q3 		– Sell
-1,605
Closed -$47.5K – 14027
2022
Q2 		$45K Buy
1,605
+971
+153% +$44.2K ﹤0.01% 12008
2022
Q1 		$45K Sell
634
-1,231
-66% -$96.7K ﹤0.01% 12873
2021
Q4 		$203K Buy
1,865
+1,318
+241% +$152K ﹤0.01% 11828
2021
Q3 		$66K Sell
547
-70
-11% -$8.17K ﹤0.01% 13207
2021
Q2 		$77K Buy
+617
New +$83.5K ﹤0.01% 13108
2020
Q2 		– Sell
-157
Closed -$12K – 10720
2020
Q1 		$12K Buy
+157
New +$16.1K ﹤0.01% 9402
2018
Q2 		– Sell
-8
Closed -$21K – 9435
2018
Q1 		$21K Buy
+8
New +$30K ﹤0.01% 8117
2017
Q4 		– Sell
-2
Closed -$18K – 8588
2017
Q3 		$18K Hold
2
– – ﹤0.01% 7380
2017
Q2 		$30K Buy
2
+1
+100% +$14.1K ﹤0.01% 7209
2017
Q1 		$23K Buy
+1
New +$17K ﹤0.01% 7219
2016
Q4 		– Sell
-1
Closed -$18K – 8026
2016
Q3 		$18K Buy
+1
New +$16.3K ﹤0.01% 7086
2016
Q1 		– Hold
0
– -$14K – 8281
2015
Q4 		– Sell
-1
Closed -$53.1K – 8157
2015
Q3 		$41K Buy
+1
New +$62.5K ﹤0.01% 7720

Other funds holding BIOC

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors's BIOC Position: Q2 2023 in Review

Citadel Advisors sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 274 shares — an estimated $2.79K sold.

Citadel Advisors first reported a position in BIOC in Q3 2015 and held it in 14 quarters. The position peaked at $203K in Q4 2021. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Citadel Advisors reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 274 Biocept, Inc. shares in Q2 2023, an estimated $2.79K.
  • Citadel Advisors first reported a position in Biocept, Inc. in Q3 2015 and held it in 14 quarters.
  • Citadel Advisors's Biocept, Inc. position peaked at $203K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.